References
1- Charlton OA, Harris V, Phan K, Mewton E, Jackson C and Cooper
A. Toxic Epidermal Necrolysis and Steven–Johnson Syndrome: A
Comprehensive Review Advances in Wound Care 2020 9:7, 426-439.
2- De Guido C, Calderaro A, Ruozi MB., et al. An unusual cause
of Steven-Johnson Syndrome. Acta Bio-medica : Atenei Parmensis. 2020
Mar;91(1):128-131.
3- Naga Subrahmanyam S, Nagaraju G V and Tagoore Vijaya Lakshmi
D. Phenytoin induced Steven Johnson syndrome. International Journal of
Research in Pharmaceutical Sciences. 2020;11(1), 173-175.
4- Johnston A and Uetrecht J. Current understanding of the
mechanism of idiosyncratic drug-induced agranulocytosis. Expert Opin
Drug Metab Toxicol. 2015;11(2):243–57.
5- Dodiuk-Gad RP, Laws PM and Shear NH. Epidemiology of severe
drug hypersensitivity. Semin Cutan Med Surg. 2014;33(1):2–9.
6- Emre S. Intravenous immunoglobulin treatment: Where do
dermatologists stand? Dermatologic Therapy. 2019; 32:e12854.